Zymeworks Announces Participation in Upcoming Investor Conference

Author's Avatar
Nov 22, 2022

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: